Thanks to the generous support of people like you, the Abigail Alliance has been advocating for people facing life-threatening illnesses since 2001. Every donation helps us continue our fight for terminally-ill patients' right to try experimental treatments.

You are welcome to designate your donation for any of several uses, including our patient access fund, which helps terminally-ill patients cover the direct costs of accessing investigational treatments. Insurance companies have thus far refused to cover any costs associated with the use of experimental treatments outside of clinical trials, and it is crucial that resources be provided to spur wider access for terminally-patients.

Funds donated to the Patient Access Fund be dispersed to providers and manufacturers on July 4th of each year. Recipients will receive funding proportional to their share of the total number of terminally-ill patients treated through pre-approval access programs.